Cision PR Newswire

SEMICONDUCTOR INDUSTRY TAKES TALENT PIPELINE TO PRIMARY SCHOOLS AND ACROSS ASIA

New initiatives will reach more than 4,000 youths in Singapore, introduce semiconductor concepts from age 10, and connect emerging talent across Asia SINGAPORE, Sept. 24, 2026 /PRNewswire/ -- Singapore's semiconductor sector is widening its talent pipeline, with new initiatives reaching students from primary-school age through to university, while...

Donghai, China, Brings Crystal and Handcrafted Press-On Nails to Milan Fashion Week

MILAN, Sept. 24, 2026 /PRNewswire/ -- Donghai County brought its crystal and handcrafted press-on...

NIKON ANNOUNCES THE Z5IIC FULL-FRAME MIRRORLESS CAMERA WITH NIKON Z MOUNT

Capture The Spark with intuitive shooting, full-frame quality and creator-friendly features SINGAPORE, Sept....

Reconova Makes Its Debut at PTE Asia 2026, Accelerating the Global Expansion of Smart Aviation through Embodied Intelligence

SINGAPORE, Sept. 24, 2026 /PRNewswire/ -- From September 23 to 24, Reconova (07656.HK) made its...

Taiwanese Team Highlights Precision Indoxyl Sulfate Testing for Early CKD Management in Japan

TOKYO, Sept. 24, 2026 /PRNewswire/ -- Chronic kidney disease (CKD) is often called a...

SF Intra-city (09699.HK) Projects Strong Annual Revenue and Profit Growth amid Surging Demand for Instant Delivery

HONG KONG, Jan. 21, 2025 /PRNewswire/ -- Hangzhou SF Intra-city Industrial Co., Ltd. ("SF Intra-city" or the "Group", Stock Code: 9699.HK), China's largest third-party...

DAHON Unveils Groundbreaking D-VELO Speed Technology at CABDA 2025 in New York

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- On January 15, the CABDA EAST Expo kicked off at the Meadowlands Exposition Center in New York, where...

YolTech Therapeutics to Initiate a Clinical Trial for YOLT-204, a First-in-Class Bone Marrow-Targeted In Vivo Gene Editing Therapy for β-Thalassemia

SHANGHAI, Jan. 21, 2025 /PRNewswire/ -- YolTech Therapeutics, a clinical-stage gene editing company dedicated to delivering lifelong cures, announced the initiation of a clinical trial...